RENAL CANCER METASTATIC

This adverse event was reported 770 times

These drugs are most commonly taken by patients reporting RENAL CANCER METASTATIC:

# Drug Count
0 SUNITINIB MALATE 196
1 PAZOPANIB HYDROCHLORIDE 90
2 CABOZANTINIB 57
3 AXITINIB 46
4 OMEPRAZOLE MAGNESIUM 40
5 ASPIRIN 38
6 ASPIRIN 325 MG 37
7 ASPIRIN 81 MG 37
8 EVEROLIMUS 35
9 NIVOLUMAB 31
See all common drugs associated with RENAL CANCER METASTATIC

RENAL CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SUNITINIB MALATE 196 0.0050
1 PAZOPANIB HYDROCHLORIDE 90 0.0033
2 TEMSIROLIMUS 15 0.0033
3 AXITINIB 46 0.0024
4 CABOZANTINIB 57 0.0012
5 ERGOCALCIFEROL 30 0.0010
6 SORAFENIB 16 0.0008
7 EVEROLIMUS 35 0.0007
8 NIVOLUMAB 31 0.0003
9 DOCUSATE SODIUM 11 0.0002
See all drugs enriched for association with RENAL CANCER METASTATIC